Medical School
Baylor College of Medicine (1996)
Baylor College of Medicine (1999), Internal Medicine
UT Southwestern Medical Center (2002), Infectious Diseases
Graduate School
University of Texas Health Science Center at Dallas (2004), Public Health
Other Post Graduate Training
University of Texas Health Science Center at Dallas (2004)

Research Interest

  • Hepatitis B
  • Hepatitis C
  • HIV and complications
  • HIV and Liver Disease
  • Influenza
  • Viral Eradication


Featured Publications LegendFeatured Publications

Access by English and Non-English Speakers Is Needed to COVID-19 Clinical Trials.
Jain MK, Rollins N, Jain R, Clin. Infect. Dis. 2020 Apr
Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment.
Wong RJ, Jain MK, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Thamer M, J Clin Exp Hepatol 2020 Mar-Apr 10 2 114-123
Patient and Provider-Level Barriers to Hepatitis C Screening and Linkage to Care: A Mixed-Methods Evaluation.
Higashi RT, Jain MK, Quirk L, Rich NE, Waljee AK, Turner BJ, Lee SC, Singal AG, J. Viral Hepat. 2020 Feb
Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial.
Ghazi L, Baker JV, Sharma S, Jain MK, Palfreeman A, Necsoi C, Murray DD, Neaton JD, Drawz PE, Am. J. Hypertens. 2020 Jan 33 1 43-52
Predictors for Poor Linkage to Care Among Hospitalized Persons Living with HIV and Co-Occurring Substance Use Disorder.
Summers N, Colasanti J, Feaster D, Armstrong W, Rodriguez A, Jain M, Jacobs P, Metsch L, Del Rio C, AIDS Res. Hum. Retroviruses 2020 Jan
HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens.
Huhn GD, Ramgopal M, Jain MK, Hinestrosa F, Asmuth DM, Slim J, Goldstein D, Applin S, Ryu JH, Jiang S, Cox S, Das M, Nguyen-Cleary T, Piontkowsky D, Guyer B, Rossaro L, Haubrich RH, PLoS ONE 2020 15 1 e0224875
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.
Davey RT, Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto MN, Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, Neaton JD, Lancet Respir Med 2019 Nov 7 11 951-963
Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults.
Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG, Hepatology 2019 Jun
Evaluation of a multifaceted intervention to reduce health disparities in hepatitis C screening: a pre-post analysis.
Jain MK, Rich NE, Ahn C, Turner BJ, Sanders JM, Adamson B, Quirk L, Perryman P, Santini NO, Singal AG, Hepatology 2019 Apr

Honors & Awards

  • Fellow of Infectious Disease Society of America
  • Best Doctors in Dallas "D Magazine"
  • K23 NIH Grant
  • Student Research Grant
  • Training Award
    Patient Oriented Research (2001)
  • Travel Grant Award
    Outstanding Abstract Submission, IDSA (2001)

Professional Associations/Affiliations

  • Texas Infectious Disease Society (2018)
  • Infectious Disease Society of America, Fellow (2015)
  • American Association for the Study of Liver Disease (2003)
  • Infectious Disease Society of America (2002)